This evidence points to the various mechanisms underlying the capacity of glioma cells to inactivate the tumor suppressor p53, favoring their survival, proliferation, migration, invasion, resistance to cell death, and metabolic reprograming. Here, TP53 is linked to central nervous system cancer.